Stocks and Investing
Stocks and Investing
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Keay Nakae Maintained (ALNY) at Strong Buy and Held Target at $225 on, May 3rd, 2024
Keay Nakae of Chardan Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $225 on, May 3rd, 2024.
Keay has made no other calls on ALNY in the last 4 months.
There are 11 other peers that have a rating on ALNY. Out of the 11 peers that are also analyzing ALNY, 6 agree with Keay's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $150 on, Friday, February 23rd, 2024
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $173 on, Friday, February 16th, 2024
- Tiago Fauth of "Wells Fargo" Maintained at Hold with Decreased Target to $161 on, Friday, February 16th, 2024
- Andy Chen of "Wolfe Research" Initiated at Hold on, Thursday, February 15th, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $176 on, Tuesday, February 13th, 2024
- Jessica Fung of "JP Morgan" Maintained at Hold with Increased Target to $170 on, Thursday, February 1st, 2024
These are the ratings of the 5 analyists that currently disagree with Keay
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $200 on, Thursday, May 2nd, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Wednesday, March 27th, 2024
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $395 on, Tuesday, March 5th, 2024
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $235 on, Wednesday, February 21st, 2024
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $227 on, Friday, February 16th, 2024
Contributing Sources